Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs
- PMID: 16403237
- PMCID: PMC1373625
- DOI: 10.1186/1465-9921-7-5
Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs
Abstract
Background: We investigated efficacy of inhaled nitric oxide (NO) in modulation of metabolism of phosphatidylcholine (PC) of pulmonary surfactant and in anti-inflammatory mechanism of mature lungs with inflammatory injury.
Methods: Healthy adult rats were divided into a group of lung inflammation induced by i.v. lipopolysaccharides (LPS) or a normal control (C) for 24 h, and then exposed to: room air (Air), 95% oxygen (O), NO (20 parts per million, NO), both O and NO (ONO) as subgroups, whereas [3H]-choline was injected i.v. for incorporation into PC of the lungs which were processed subsequently at 10 min, 4, 8, 12 and 24 h, respectively, for measurement of PC synthesis and proinflammatory cytokine production.
Results: LPS-NO subgroup had the lowest level of labeled PC in total phospholipids and disaturated PC in bronchoalveolar lavage fluid and lung tissue (decreased by 46-59%), along with the lowest activity of cytidine triphosphate: phosphocholine cytidylyltransferase (-14-18%) in the lungs, compared to all other subgroups at 4 h (p < 0.01), but not at 8 and 12 h. After 24-h, all LPS-subgroups had lower labeled PC than the corresponding C-subgroups (p < 0.05). LPS-ONO had higher labeled PC in total phospholipids and disaturated PC, activity of cytidylyltransferase, and lower activity of nuclear transcription factor-kappaB and expression of proinflammatory cytokine mRNA, than that in the LPS-O subgroup (p < 0.05).
Conclusion: In LPS-induced lung inflammation in association with hyperoxia, depressed PC synthesis and enhanced proinflammatory cytokine production may be alleviated by iNO. NO alone only transiently suppressed the PC synthesis as a result of lower activity of cytidylyltransferase.
Figures







Similar articles
-
Inhaled nitric oxide attenuates hyperoxic and inflammatory injury without alteration of phosphatidylcholine synthesis in rat lungs.Pulm Pharmacol Ther. 2007;20(1):75-84. doi: 10.1016/j.pupt.2005.12.008. Epub 2006 Feb 9. Pulm Pharmacol Ther. 2007. PMID: 16480908
-
Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury.Thromb Res. 2015 Jul;136(1):131-8. doi: 10.1016/j.thromres.2015.04.018. Epub 2015 Apr 22. Thromb Res. 2015. PMID: 25934465
-
Anti-inflammatory effects of inhaled nitric oxide are optimized at lower oxygen concentration in experimental Klebsiella pneumoniae pneumonia.Inflamm Res. 2006 Oct;55(10):430-40. doi: 10.1007/s00011-006-6029-7. Inflamm Res. 2006. PMID: 17109070
-
Endostatin and vascular endothelial cell growth factor (VEGF) in piglet lungs: effect of inhaled nitric oxide and hyperoxia.Pediatr Res. 2003 Mar;53(3):440-6. doi: 10.1203/01.PDR.0000050121.70693.1A. Pediatr Res. 2003. PMID: 12595592
-
[Effect of inhaled nitric oxide on surfactant protein A and mannose binding ability in the lung of neonatal rats with hyperoxia-induced lung injury].Zhongguo Dang Dai Er Ke Za Zhi. 2006 Dec;8(6):486-90. Zhongguo Dang Dai Er Ke Za Zhi. 2006. PMID: 17178042 Chinese.
Cited by
-
The nitric oxide donor, (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NONOate/D-NO), increases survival by attenuating hyperoxia-compromised innate immunity in bacterial clearance in a mouse model of ventilator-associated pneumonia.Biochem Pharmacol. 2020 Jun;176:113817. doi: 10.1016/j.bcp.2020.113817. Epub 2020 Jan 20. Biochem Pharmacol. 2020. PMID: 31972169 Free PMC article.
-
Structural Characterization and Efficacy in Alleviating Lung Inflammation of Sialylated Glycopeptides from Edible Bird's Nest.Nutrients. 2025 May 21;17(10):1745. doi: 10.3390/nu17101745. Nutrients. 2025. PMID: 40431484 Free PMC article.
-
Effects of acute intravenous lipopolysaccharide administration on the plasma lipidome and metabolome in lactating Holstein cows experiencing hyperlipidemia.Metabolomics. 2022 Sep 19;18(10):75. doi: 10.1007/s11306-022-01928-1. Metabolomics. 2022. PMID: 36125563
-
The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?Front Pediatr. 2021 Mar 31;9:631765. doi: 10.3389/fped.2021.631765. eCollection 2021. Front Pediatr. 2021. PMID: 33869113 Free PMC article. Review.
-
Nitric oxide and hyperoxic acute lung injury.Med Gas Res. 2016 Jul 11;6(2):85-95. doi: 10.4103/2045-9912.184718. eCollection 2016 Apr-Jun. Med Gas Res. 2016. PMID: 27867474 Free PMC article. Review.
References
-
- Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;147:218–33. - PubMed
-
- Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–24. - PubMed
-
- Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H. Effectiveness of nitric oxide inhalation in septic ARDS. Chest. 1996;109:486–93. - PubMed
-
- Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K, Jr, Hyers TM, Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med. 1998;26:15–23. doi: 10.1097/00003246-199801000-00011. - DOI - PubMed
-
- Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Ducruet T, Francoeur M, Charbonneau M, Blaise G. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998;157:1483–88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical